SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001140361-24-038067
Filing Date
2024-08-21
Accepted
2024-08-21 16:02:05
Documents
5
Period of Report
2024-09-18

Document Format Files

Seq Description Document Type Size
1 DEF 14A ny20032269x2_def14a.htm DEF 14A 191967
2 logo_neurobo.jpg GRAPHIC 50705
3 ny20032269x1_pc01.jpg GRAPHIC 680994
4 ny20032269x1_pc02.jpg GRAPHIC 440017
5 sig_andrewkoven.jpg GRAPHIC 35268
  Complete submission text file 0001140361-24-038067.txt   1854527
Mailing Address 545 CONCORD AVENUE SUITE 210 CAMBRIDGE MA 02138
Business Address 545 CONCORD AVENUE SUITE 210 CAMBRIDGE MA 02138 (857) 702-9600
NeuroBo Pharmaceuticals, Inc. (Filer) CIK: 0001638287 (see all company filings)

IRS No.: 472389984 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-37809 | Film No.: 241228731
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)